Conjugate vaccine introduction in the African meningitis belt: Meeting surveillance objectives

Tropical Medicine and International Health

Volumn 18, Issue 1, 2013, Pages 58-64

  Mueller, Judith E ^a,b  

^a EHESP SCHOOL OF PUBLIC HEALTH   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Conjugate vaccine; Meningococcus; Serogroup A; Surveillance

Indexed keywords

MENINGOCOCCUS VACCINE;

EPIDEMIOLOGY; HEALTH RISK; MENINGITIS; PNEUMONIA; PUBLIC HEALTH; VACCINATION; VACCINE;

AFRICA; ARTICLE; BACTERIAL MENINGITIS; CLINICAL DECISION MAKING; EPIDEMIC; HEALTH CENTER; HEALTH SURVEY; HUMAN; INCIDENCE; MASS IMMUNIZATION; MOLECULAR DIAGNOSTICS; NEISSERIA MENINGITIDIS; PNEUMONIA; POLYMERASE CHAIN REACTION;

AFRICA; DISEASE OUTBREAKS; EPIDEMICS; HUMANS; INCIDENCE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL VACCINES; PNEUMONIA; POPULATION SURVEILLANCE; VACCINATION; VACCINES, CONJUGATE;

AFRICA;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

EID: 84871701199     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12009     Document Type: Article

References (40)

1. Alio Sanda AK, Jusot JF, Alkassoum B & Collard JM. (2011) Determination of pneumococcal serotypes in meningitis cases in Niger, 2003-2011. Poster presented at the Meningitis and Septicemia in Children and Adults 2011 Conference of the Meningitis Research Foundation, London, 8-9 November, 2011. http://www.meningitis.org/posters
2. Broome CV, Rugh MA & Yada AA et al. (1983) Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bulletin of the World Health Organization61, 325-330.
3. Campagne G, Schuchat A, Djibo S, Ousséini A, Cissé L & Chippaux JP (1999) Epidemiology of bacterial meningitis in Niamey, Niger, 1981-1996. Bulletin of the World Health Organization77, 499-508.
4. Centers for Disease Control Prevention (2009) Pediatric bacterial meningitis surveillance - African Region, 2002-2008. Morbidity and Mortality Weekly Report58, 493-497.
5. Chanteau S, Sidikou F, Djibo S, Moussa A, Mindadou H & Boisier P (2006) Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger. Transactions of the Royal Society of Tropical Medicine and Hygiene100, 677-680.
6. Chen RT & Orenstein WA (1996) Epidemiologic methods in immunization programs. Epidemiologic reviews18, 99-117.
7. Collard JM, Maman Z, Abani A et al. (2011) Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?Epidemiology and Infection139, 1656-1660.
8. Cutts FT, Zaman SM, Enwere G et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet365, 1139-1146.
9. Delrieu I, Yaro S, Tamekloé TAS et al. (2011) Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso. PLoS ONE6, e19513.
10. Gessner BD, Mueller JE & Yaro S (2010) African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infectious Diseases10, 22.
11. Giesecke J (Ed) 2002) Routine surveillance of infectious diseases. in: Modern Infectious Disease Epidemiology. 2nd Ed. Edward Arnold, London, pp. 149.
12. Greenwood B (1999) Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene93, 341-353.
13. Hassan-King M, Greenwood BM & Whittle HC (1979) An epidemic of meningococcal infection at Zaria, Northern Nigeria. 3. Meningococcal carriage. Transactions of the Royal Society of Tropical Medicine and Hygiene73, 567-573.
14. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N & Pierce N (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New England Journal of Medicine349, 1341-1348.
15. LaForce MF & Okwo-Bele JM (2011) Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine. Health Affairs6, 1049-1057.
16. Lapeyssonnie L (1963) La méningite cérébro-spinale en Afrique (Cerebrospinal meningitis in Africa). Bulletin of the World Health Organization28(Suppl), 3-114.
17. Leake JAD, Kone ML, Yada A et al. (2002) Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bulletin of the World Health Organization80, 342-349.
18. Leimkugel J, Forgor AA, Gangeux S et al. (2005) An outbreak of serotype 1 Streptococcus pneumoniae meningitis in Northern Ghana with features those are characteristic of Neisseria meningitidis meningitis epidemics. Journal of Infectious Diseases192, 192-199.
19. Leimkugel J, Hodgson A, Forgor AA et al. (2007) Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight-year longitudinal study in northern Ghana. PLoS Medicine27, e101.
20. Massenet D, Inrombe J, Mevoula DA & Nicolas P (2009) Serogroup W135 meningococcal meningitis, Northern Cameroon, 2007-2008. Emerging Infectious Diseases15, 340-342.
21. Mueller JE & Gessner BD (2010) A hypothetical model for meningococcal meningitis in the African meningitis belt. International Journal of Infectious Diseases15, e553-e559.
22. Mueller JE, Yaro S, Njanpop-Lafourcade BM et al. (2011) Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage and immunity. Journal of Infectious Diseases204, 1787-1795.
23. Nicolas P, Norheim G, Garnotel E, Djibo S & Caugant DA (2005) Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. Journal of Clinical Microbiology43, 5129-5135.
24. Njanpop Lafourcade BM, Sanou O, Van der Linden M et al. (2010) Serotyping pneumococcal meningitis cases in the African meningitis belt using multiplex PCR on cerebrospinal fluid. Journal of Clinical Microbiology48, 612-614.
25. Paireau J, Girond F, Collard JM, Maïnassara HB & Jusot JF (2012) Analysing spatio-temporal clustering of meningococcal meningitis outbreaks in Niger reveals opportunities for improved disease control. PLoS Neglected Tropical Diseases6, e1577.
26. Parent du Chatelet I, Traoré Y, Gessner BD et al. (2005) Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clinical Infectious Diseases40, 17-25.
27. Roberts L (2010) Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks?Science330, 1466-1467.
28. Rose AMC, Mueller JE, Gerstl S et al. (2010) Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007. PLoS ONE5, e11086.
29. Sidikou F, Djibo S, Taha MK et al. (2003) Polymerase chain reaction assay and bacterial meningitis surveillance in remote areas, Niger. Emerging Infectious Diseases9, 1486-1488.
30. Sié A, Pflüger V, Coulibaly B et al. (2008) ST-2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study. Tropical Medicine and International Health13, 861-868.
31. Soriano-Gabarró M, Toé L & Tiendebeogo SRM et al. (2007) Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003. Vaccine25(Suppl), A92-A96.
32. Sow SO, Okoko BJ, Diallo A et al. (2011) Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. New England Journal of Medicine364, 2293-2304.
33. Tall H, Hugonnet S, Donnen P et al. (2012a) Definition and characterization of localized meningitis epidemics in Burkina Faso. BMC Infectious Diseases12, 2.
34. Tall H, Agbenoko K & Tamekloe ST et al. (2012b) Seasonality of clinical and pneumococcal pneumonia in the African meningitis belt, Togo 2010-2011. Poster presented at the 8th International Symposium on Pneumococci and Pneumococcal Diseases, Iguaçu Falls, Brazil, 11-15 March 2012. Abstract book, 57 (No. 28). http://www2.kenes.com/ISPPD/Scientific/Documents/FinalAbstractbook.pdf
35. Thomson MC, Molesworth AM, Djingarey MH, Tameogo KR, Belanger F & Cuevas LE (2006) Potential of environmental models to predict meningitis epidemics in Africa. Tropical Medicine and International Health11, 781-788.
36. World Health Organization (2000) Detecting meningococcal meningitis epidemics in highly-endemic African countries. Weekly Epidemiological Record75, 305-312.
37. World Health Organization (2007) Global framework for immunization monitoring and surveillance. http://whqlibdoc.who.int/hq/2007/WHO_IVB_07.06_eng.pdf
38. World Health Organization, Regional Office for Africa (2009) Standard operating procedures for Enhanced Meningitis Surveillance in Africa. http://www.meningvax.org/files/WHO_SOP_EN_2009.pdf
39. World Health Organization, Regional Office for Africa (2011) Meningitis Weekly Bulletin, week 48-52, 2011. http://www.meningvax.com/files/BulletinMeningite2011_S48_52.pdf
40. World Health Organization, Regional Office for Africa (2012) Meningitis Weekly Bulletin, week 14, 2012. http://www.meningvax.com/files/BulletinMeningite2012_S12.pdf